Results 261 to 270 of about 1,574,797 (410)

A potential strategy for improving offspring behavior in maternal immune activation: Amantadine‐mediated suppression of neuroinflammation

Animal Models and Experimental Medicine, EarlyView.
Amantadine (AMA) regulates neurocyte apoptosis and inhibits neurocyte inflammation to prevent maternal immune activation (MIA) from affecting offspring behavior. Abstract Background Maternal viral infection during pregnancy can lead to maternal immune activation (MIA), increasing the risk of neurodevelopmental disorders in offspring.
Jianfei Wu, Yu Liu, Binglong Wang, Yilin Wang, Bo Liu, Youguo Tan, Duanfang Cai, Kezhi Liu, Daixu Wei   +8 more
wiley   +1 more source

Efficacy and Safety of Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Spinal Fusion Outcomes: A Comprehensive Meta-Analysis. [PDF]

Cureus
Zahed M, Elmesalmi M, Al-Kharouf KF, Elbahnasawy SE, El Menawy Z, Elhanash S, Odeh M, Elnaggar N, Hesham Gamal M, Elhady MM.   +9 more
europepmc   +1 more source

Considerations in the Use of COX-2 Inhibitors in Spinal Fusion Surgery

, 2001
Jerry S. Matsumura
openalex   +1 more source

Pelvic Girdle Reconstruction Based on Spinal Fusion and IschialScrew Fixation in a Case of Aneurysmal Bone Cyst [PDF]

, 2003
M. Honl, Florian Westphal, Volker Carrero, Michael M. Morlock, Karsten Schwieger, Ekkehard Hille, G. Delling   +6 more
openalex   +1 more source

Brief Report: Human Perivascular Stem Cells and Nel‐Like Protein‐1 Synergistically Enhance Spinal Fusion in Osteoporotic Rats

Stem Cells, 2015
Soonchul Lee, Xinli Zhang, Jia Shen, A. James, Choon G. Chung, Reef Hardy, Chenshuang Li, Caroline Girgius, Yulong Zhang, David Stoker, Huiming Wang, Ben Wu, B. Péault, K. Ting, C. Soo   +14 more
semanticscholar   +1 more source

Exenatide Once Weekly in the Treatment of Patients with Multiple System Atrophy

Annals of Neurology, EarlyView.
Objective Exenatide, a glucagon‐like peptide‐1 (GLP‐1) receptor agonist, has neuroprotective effects in preclinical models of multiple system atrophy (MSA). We investigated these effects in a proof‐of‐concept clinical trial. Methods In this single‐center, randomized, open label trial, participants with MSA were randomly assigned (1:1) to receive ...
Nirosen Vijiaratnam, Christine Girges, Martin Wiegand, Claudia Ismail, Alexandra Lameirinhas, Alison Yarnall, Cameron Kirk, Silvia Del‐Din, Lynn Rochester, Christopher Kobylecki, Gareth Ambler, Simon Skene, Henry Houlden, Viorica Chelban, Amanda Heslegrave, Wendy Phillips, Alan Whone, Niall Quinn, Christian Lambert, Charlotte Dore, Huw R. Morris, Mathew H. Horrocks, Ji Eun Lee, Judi O'Shaughnessy, Yazhou Li, Nigel H. Greig, Sonia Gandhi, Vincenzo Libri, Dilan Athauda, Tom Foltynie   +29 more
wiley   +1 more source

Robotic assisted anterior lumbar interbody fusion with the use of indocyanine green and posterior spinal fusion. [PDF]

Neurosurg Focus Video
Decker I, Hunter E, Seo LJ, Landen A, Goodwin CR, Erickson M, Zani S, Abd-El-Barr MM.   +7 more
europepmc   +1 more source

Life expectancy in pediatric patients with cerebral palsy and neuromuscular scoliosis who underwent spinal fusion [PDF]

, 2003
Athanasios I. Tsirikos, Freeman Miller, Joseph J. Glutting   +2 more
openalex   +1 more source

Phenotypic Changes in a Monocyte Cluster with High Interleukin‐1 Beta Expression during Long‐Term Anti‐CD20 Therapy

Annals of Neurology, EarlyView.
Graphical abstract illustrating the study design, experimental workflow, and key findings from single‐cell profiling of peripheral mononuclear cells in multiple sclerosis patients undergoing anti‐CD20 therapy, revealing disease‐ and treatment‐associated immune signatures.
Mie Waede, Christina Kingo, Karina Damsbo, Maiken Uhrbrand Joergensen, Mhaned Oubounyt, Morten Gjerstorff, Mads Thomassen, Jan Baumbach, Jesper B. Moeller, Maria L. Elkjaer, Zsolt Illes   +10 more
wiley   +1 more source

Personalized porous tantalum implants crafted via 3D printing: new horizons in complex cervical-thoracic spinal fusion. [PDF]

Front Bioeng Biotechnol
Chen C, Fan H, Chen G, Li Z, Wang P, Wang F.   +5 more
europepmc   +1 more source